Terms: = Leukemia AND ETNK1, ENSG00000139163, 55500, Q9HBU6, Nbla10396, EKI1, EKI
12 results:
1. Atypical CML: diagnosis and treatment.
Breccia M
Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):476-482. PubMed ID: 38066919
[TBL] [Abstract] [Full Text] [Related]
2.
Iaquinta G; Scalzulli E; Angeloni S; Carmosino I; Costa A; Ielo C; Passucci M; Masucci C; Martelli M; Grammatico P; Breccia M
Leuk Lymphoma; 2023 Oct; 64(10):1730-1732. PubMed ID: 37435984
[TBL] [Abstract] [Full Text] [Related]
3. Atypical chronic myeloid leukemia and myelodysplastic/myeloproliferative neoplasm, not otherwise specified: 2023 update on diagnosis, risk stratification, and management.
Patnaik MM; Tefferi A
Am J Hematol; 2023 Apr; 98(4):681-689. PubMed ID: 36601682
[TBL] [Abstract] [Full Text] [Related]
4. etnk1 mutation occurs in a wide spectrum of myeloid neoplasms and is not specific for atypical chronic myeloid leukemia.
Shuai W; Zuo Z; Li N; Garces S; Jelloul FZ; Ok CY; Li S; Xu J; You MJ; Wang W; Rehder C; Jabbour EJ; Patel KP; Medeiros LJ; Yin CC
Cancer; 2023 Mar; 129(6):878-889. PubMed ID: 36583229
[TBL] [Abstract] [Full Text] [Related]
5. Genomics of myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes.
Patnaik MM; Lasho TL
Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):450-459. PubMed ID: 33275756
[TBL] [Abstract] [Full Text] [Related]
6. etnk1 mutations induce a mutator phenotype that can be reverted with phosphoethanolamine.
Fontana D; Mauri M; Renso R; Docci M; Crespiatico I; Røst LM; Jang M; Niro A; D'Aliberti D; Massimino L; Bertagna M; Zambrotta G; Bossi M; Citterio S; Crescenzi B; Fanelli F; Cassina V; Corti R; Salerno D; Nardo L; Chinello C; Mantegazza F; Mecucci C; Magni F; Cavaletti G; Bruheim P; Rea D; Larsen S; Gambacorti-Passerini C; Piazza R
Nat Commun; 2020 Nov; 11(1):5938. PubMed ID: 33230096
[TBL] [Abstract] [Full Text] [Related]
7. Atypical Chronic Myeloid leukemia: Where Are We Now?
Crisà E; Nicolosi M; Ferri V; Favini C; Gaidano G; Patriarca A
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32962122
[TBL] [Abstract] [Full Text] [Related]
8. Atypical chronic myeloid leukemia: a rare entity with management challenges.
Dhakal P; Gundabolu K; Amador C; Rayamajhi S; Bhatt VR
Future Oncol; 2018 Jan; 14(2):177-185. PubMed ID: 29226717
[TBL] [Abstract] [Full Text] [Related]
9. Targeted next generation sequencing and identification of risk factors in World Health Organization defined atypical chronic myeloid leukemia.
Patnaik MM; Barraco D; Lasho TL; Finke CM; Reichard K; Hoversten KP; Ketterling RP; Gangat N; Tefferi A
Am J Hematol; 2017 Jun; 92(6):542-548. PubMed ID: 28314085
[TBL] [Abstract] [Full Text] [Related]
10. Novel recurrent mutations in ethanolamine kinase 1 (etnk1) gene in systemic mastocytosis with eosinophilia and chronic myelomonocytic leukemia.
Lasho TL; Finke CM; Zblewski D; Patnaik M; Ketterling RP; Chen D; Hanson CA; Tefferi A; Pardanani A
Blood Cancer J; 2015 Jan; 5(1):e275. PubMed ID: 25615281
[TBL] [Abstract] [Full Text] [Related]
11. Recurrent etnk1 mutations in atypical chronic myeloid leukemia.
Gambacorti-Passerini CB; Donadoni C; Parmiani A; Pirola A; Redaelli S; Signore G; Piazza V; Malcovati L; Fontana D; Spinelli R; Magistroni V; Gaipa G; Peronaci M; Morotti A; Panuzzo C; Saglio G; Usala E; Kim DW; Rea D; Zervakis K; Viniou N; Symeonidis A; Becker H; Boultwood J; Campiotti L; Carrabba M; Elli E; Bignell GR; Papaemmanuil E; Campbell PJ; Cazzola M; Piazza R
Blood; 2015 Jan; 125(3):499-503. PubMed ID: 25343957
[TBL] [Abstract] [Full Text] [Related]
12. [The regulation of eki-785 to the growth of U937 cell line].
Yuan XF; Lu SH; Feng Y; Liu N; Song X; Lu M
Zhonghua Zhong Liu Za Zhi; 2006 Nov; 28(11):810-4. PubMed ID: 17416000
[TBL] [Abstract] [Full Text] [Related]
